Nasdaq
$6.47▲ 0.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $464.9MShares out 71.9M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
1- 8.17Pre-market26.08.17 21:116-KKey event#●●●#●●●
SINOVAC BIOTECH LTDBullish
Sinovac Biotech reported $147.1 million in revenue for the first half of 2026, a 12.9% increase year-over-year, but net loss attributable to common shareholders widened to $60.2 million ($0.84 per share). While overseas revenue surged by 82.3%, the company faced headwinds from declining domestic demand due to lower birth rates in China and reduced investment income.…more
$6.47+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
News
GlobeNewswire- 6d agoPre-market26.10.19 20:00#●●●#●●●
Seraxis and Sernova Appoint Former FDA Medical Officer as CMO
Seraxis and Sernova have appointed former FDA official Dr. Patricia Beaston as Chief Medical Officer for their upcoming merged entity, BetaNova. The appointment aims to strengthen regulatory leadership ahead of the planned Phase 1/2 clinical trial for their diabetes treatment in early 2027.…more
$6.47+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.5Pre-market26.10.05 20:00
●●●●●●●● ●●●●● ●●●●●●
Sernova and Seraxis have raised $11.2 million to fund their merger into BetaNova Biotherapeutics. The proceeds will support upcoming Phase 1/2 clinical trials for type 1 diabetes and preparations for a Nasdaq listing.…more
$6.47+0.00%vs prev close - 9.25Pre-market26.09.25 20:00
●●●●●●●● ●●●●● ●●●●●●
Sernova Biotherapeutics will participate in an investor conference to discuss its proposed merger with Seraxis and the formation of BetaNova Biotherapeutics. The presentation will highlight the integration of their respective technologies to advance type 1 diabetes cell-replacement therapies.…more
$6.47+0.00%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report